(1)
Shi, X.; Wang, W. J.; He, K. J.; Wang, D. C.; Li, X. Q.; Li, X. Pathological Complete Response in Stage IV Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer With Synchronous Liver Metastases After Conversion Therapy With SOX Plus Cadonilimab and Disitamab Vedotin. Gastroenterol Res 2026, 19 (5), 295-301. https://doi.org/10.14740/gr2193.